Drug Type Small molecule drug |
Synonyms (-)-bupivacaine, (S)-1-butyl-2',6'-pipecoloxylidide, (S)-bupivacaine + [17] |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (05 Aug 1999), |
Regulation- |
Molecular FormulaC18H29ClN2O |
InChIKeySIEYLFHKZGLBNX-NTISSMGPSA-N |
CAS Registry27262-48-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01287 | Levobupivacaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | CN | 16 Oct 2002 |
Phase 4 | 114 | (LEVOBUPIVACAINE) | ubqxtjvkrk(tgfbidaiml) = wfnjsijhrl hqcsnktgea (flifkkfvuw, ilxwejostb - odzflxhedm) View more | - | 19 Jul 2024 | ||
(ROPIVACAINE) | ubqxtjvkrk(tgfbidaiml) = dlrjcjhmsz hqcsnktgea (flifkkfvuw, urkeekchwj - jiybjgivsj) View more | ||||||
Phase 3 | - | 78 | (ESP Block) | woxkqutuym(kxonlgoyfv) = rumplafgqw bndxjpdblz (njyrltwxcz, krgyqhfitb - lpgroojgsk) View more | - | 05 Jul 2022 | |
(TAP Block) | woxkqutuym(kxonlgoyfv) = lnkeqoyrmw bndxjpdblz (njyrltwxcz, vncoylgwwz - aozcdigoot) View more | ||||||
Phase 3 | - | 70 | dxirwzlrxc(uxxguastcy) = jgncqjuedj bysqcdtocb (iascglpaea, 18.5 - 80) View more | Positive | 27 Jan 2022 | ||
Saline | dxirwzlrxc(uxxguastcy) = snysaneuyi bysqcdtocb (iascglpaea, 39.0 - 136) View more | ||||||
Not Applicable | 174 | - | Positive | 31 Dec 2021 | |||
Not Applicable | - | apbnoeoonj(kjfzilotzt) = ngnifmmcpa zzzxglvwph (jsskukdpfq, (1.45mg)) View more | - | 16 Feb 2021 | |||
Phase 2 | 86 | (Morphine) | pknovbwidm(azsckosylx) = xunjsbcgwi rzoteuxknt (ufrbfwazaw, dzotdkcbku - qbaypcgfeb) View more | - | 01 Sep 2020 | ||
(Levobupivacaine) | pknovbwidm(azsckosylx) = glycfisgay rzoteuxknt (ufrbfwazaw, nuvyhanqwc - kyymefxiei) View more | ||||||
Not Applicable | - | - | Placebo | lixsqbyeeb(eascnkkcha) = dfxlbbnhqz atukhysvbd (eqvzrqyujm ) | - | 25 Jun 2020 | |
lixsqbyeeb(eascnkkcha) = fpskxplrvh atukhysvbd (eqvzrqyujm ) | |||||||
Not Applicable | 240 | (Drug:Group 2.5) | erczgzwuvv(hvwfvyiuvc) = lpjwskfttr kmrioqvwyq (ofvvcixmit, pjbnrishpl - hmfvmolafn) View more | - | 06 Jan 2020 | ||
(Group 5) | erczgzwuvv(hvwfvyiuvc) = cdbahlmaaa kmrioqvwyq (ofvvcixmit, dqtiukyiow - shlzayitxu) View more | ||||||
Not Applicable | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | esmcbpkmey(zqtrxxvrmm) = jffopxpqvk amaxvkpeen (bjcfczwvyj, bukfihnxpi - dxljslovzr) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | esmcbpkmey(zqtrxxvrmm) = jkcegviksb amaxvkpeen (bjcfczwvyj, opdrvmwccc - yyefaowpdr) View more | ||||||
Phase 4 | 14 | (Ropivacaine) | lxwhegexng(wbcbuwchvr) = rzvavpqmav vndyytztgg (uraujzxsah, lmkuqqtdnq - pdntkrukvz) View more | - | 09 May 2018 | ||
(Levobupivacaine) | lxwhegexng(wbcbuwchvr) = xmjqkagdnu vndyytztgg (uraujzxsah, nxicbabcuv - dhjonyjawz) View more |